- 如果營收成長率小於推銷費用成長率, 可能代表產品需要很多的促銷才能賣掉, 或是產品有問題需要花額外的推銷成本來善後
- 發展品牌的公司不樂見推銷費用率的下滑, 對此類型公司推銷費用率等同於走技術類型公司的研發費用率
| 營收淨額 QoQ YoY | 推銷費用 QoQ YoY | 管理費用 QoQ YoY | 研發費 QoQ YoY | 推銷費用率(%) QoQ YoY | 管理費用率(%) QoQ YoY | 研發費用率(%) QoQ YoY | 員工人數 QoQ YoY | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | 3.21 | 55.07 | 197.22 | 0 | 0 | 0 | 0.27 | 8.0 | 22.73 | 0 | 0 | 0 | 0.00 | 0 | 0 | 8.41 | -30.36 | -58.71 | 0.00 | 0 | 0 | 83 | 0.0 | -49.7 |
| 24Q2 (19) | 2.07 | 111.22 | 68.29 | 0 | 0 | 0 | 0.25 | 13.64 | 8.7 | 0 | 0 | 0 | 0.00 | 0 | 0 | 12.08 | -46.2 | -35.41 | 0.00 | 0 | 0 | 83 | 0.0 | -49.7 |
| 24Q1 (18) | 0.98 | -37.97 | -53.55 | 0 | 0 | 0 | 0.22 | -43.59 | 22.22 | 0 | 0 | 0 | 0.00 | 0 | 0 | 22.45 | -9.05 | 163.15 | 0.00 | 0 | 0 | 83 | 0.0 | -49.7 |
| 23Q4 (17) | 1.58 | 46.3 | -38.28 | 0 | 0 | 0 | 0.39 | 77.27 | 14.71 | 0 | 0 | 0 | 0.00 | 0 | 0 | 24.68 | 21.17 | 85.85 | 0.00 | 0 | 0 | 83 | -49.7 | -49.7 |
| 23Q3 (16) | 1.08 | -12.2 | -5.26 | 0 | 0 | 0 | 0.22 | -4.35 | -31.25 | 0 | 0 | 0 | 0.00 | 0 | 0 | 20.37 | 8.94 | -27.43 | 0.00 | 0 | 0 | 165 | 0.0 | 70.1 |
| 23Q2 (15) | 1.23 | -41.71 | -68.22 | 0 | 0 | 0 | 0.23 | 27.78 | -8.0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 18.70 | 119.2 | 189.46 | 0.00 | 0 | 0 | 165 | 0.0 | 70.1 |
| 23Q1 (14) | 2.11 | -17.58 | -59.89 | 0 | 0 | 0 | 0.18 | -47.06 | -33.33 | 0 | 0 | 0 | 0.00 | 0 | 0 | 8.53 | -35.77 | 66.19 | 0.00 | 0 | 0 | 165 | 0.0 | 70.1 |
| 22Q4 (13) | 2.56 | 124.56 | -20.25 | 0 | 0 | 0 | 0.34 | 6.25 | -12.82 | 0 | 0 | 0 | 0.00 | 0 | 0 | 13.28 | -52.69 | 9.31 | 0.00 | 0 | 0 | 165 | 70.1 | 70.1 |
| 22Q3 (12) | 1.14 | -70.54 | -65.45 | 0 | 0 | 0 | 0.32 | 28.0 | -20.0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 28.07 | 334.53 | 131.58 | 0.00 | 0 | 0 | 97 | 0.0 | -53.59 |
| 22Q2 (11) | 3.87 | -26.43 | -27.53 | 0 | 0 | 0 | 0.25 | -7.41 | -37.5 | 0 | 0 | 0 | 0.00 | 0 | 0 | 6.46 | 25.85 | -13.76 | 0.00 | 0 | 0 | 97 | 0.0 | -53.59 |
| 22Q1 (10) | 5.26 | 63.86 | 21.48 | 0 | 0 | 0 | 0.27 | -30.77 | -38.64 | 0 | 0 | 0 | 0.00 | 0 | 0 | 5.13 | -57.75 | -49.49 | 0.00 | 0 | 0 | 97 | 0.0 | -53.59 |
| 21Q4 (9) | 3.21 | -2.73 | -31.41 | 0 | 0 | 0 | 0.39 | -2.5 | -35.0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 12.15 | 0.23 | -5.23 | 0.00 | 0 | 0 | 97 | -53.59 | -53.59 |
| 21Q3 (8) | 3.3 | -38.2 | -7.04 | 0 | 0 | 0 | 0.4 | 0.0 | -14.89 | 0 | 0 | 0 | 0.00 | 0 | 0 | 12.12 | 61.82 | -8.45 | 0.00 | 0 | 0 | 209 | 0.0 | 45.14 |
| 21Q2 (7) | 5.34 | 23.33 | 30.24 | 0 | 0 | 0 | 0.4 | -9.09 | -14.89 | 0 | 0 | 0 | 0.00 | 0 | 0 | 7.49 | -26.29 | -34.66 | 0.00 | 0 | 0 | 209 | 0.0 | 45.14 |
| 21Q1 (6) | 4.33 | -7.48 | 7.98 | 0 | 0 | 0 | 0.44 | -26.67 | -12.0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 10.16 | -20.74 | -18.5 | 0.00 | 0 | 0 | 209 | 0.0 | 32.28 |
| 20Q4 (5) | 4.68 | 31.83 | 80.0 | 0 | 0 | 0 | 0.6 | 27.66 | 5.26 | 0 | 0 | 0 | 0.00 | 0 | 0 | 12.82 | -3.16 | -41.52 | 0.00 | 0 | 0 | 209 | 45.14 | 32.28 |
| 20Q3 (4) | 3.55 | -13.41 | 0.0 | 0 | 0 | 0.0 | 0.47 | 0.0 | 0.0 | 0 | 0 | 0.0 | 0.00 | 0 | 0.0 | 13.24 | 15.49 | 0.0 | 0.00 | 0 | 0.0 | 144 | 0.0 | 0.0 |
| 20Q2 (3) | 4.1 | 2.24 | 0.0 | 0 | 0 | 0.0 | 0.47 | -6.0 | 0.0 | 0 | 0 | 0.0 | 0.00 | 0 | 0.0 | 11.46 | -8.06 | 0.0 | 0.00 | 0 | 0.0 | 144 | -8.86 | 0.0 |
| 20Q1 (2) | 4.01 | 54.23 | 0.0 | 0 | 0 | 0.0 | 0.5 | -12.28 | 0.0 | 0 | 0 | 0.0 | 0.00 | 0 | 0.0 | 12.47 | -43.12 | 0.0 | 0.00 | 0 | 0.0 | 158 | 0.0 | 0.0 |
| 19Q4 (1) | 2.6 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0.57 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0.00 | 0.0 | 0.0 | 21.92 | 0.0 | 0.0 | 0.00 | 0.0 | 0.0 | 158 | 0.0 | 0.0 |
| 營收淨額 YoY | 推銷費用 YoY | 管理費用 YoY | 研發費 YoY | 推銷費用率(%) YoY | 管理費用率(%) YoY | 研發費用率(%) YoY | 員工人數 YoY | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 6.0 | -53.23 | 0 | 0 | 1.02 | -14.29 | 0 | 0 | 0.00 | 0 | 17.00 | 83.29 | 0.00 | 0 | 165 | 0.0 |
| 2022 (9) | 12.83 | -20.75 | 0 | 0 | 1.19 | -26.99 | 0 | 0 | 0.00 | 0 | 9.28 | -7.87 | 0.00 | 0 | 165 | 70.1 |
| 2021 (8) | 16.19 | -0.86 | 0 | 0 | 1.63 | -20.49 | 0 | 0 | 0.00 | 0 | 10.07 | -19.8 | 0.00 | 0 | 97 | -53.59 |
| 2020 (7) | 16.33 | 53.33 | 0 | 0 | 2.05 | -11.26 | 0 | 0 | 0.00 | 0 | 12.55 | -42.12 | 0.00 | 0 | 209 | 45.14 |
| 2019 (6) | 10.65 | -18.89 | 0 | 0 | 2.31 | 15.5 | 0 | 0 | 0.00 | 0 | 21.69 | 42.4 | 0.00 | 0 | 144 | -8.86 |
| 2018 (5) | 13.13 | -15.56 | 0 | 0 | 2.0 | 76.99 | 0 | 0 | 0.00 | 0 | 15.23 | 109.61 | 0.00 | 0 | 158 | 9.72 |
| 2017 (4) | 15.55 | -12.25 | 0 | 0 | 1.13 | 0 | 0 | 0 | 0.00 | 0 | 7.27 | 0 | 0.00 | 0 | 144 | -13.25 |
| 2016 (3) | 17.72 | 58.21 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 166 | 0.0 |
| 2015 (2) | 11.2 | -22.87 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 166 | 0.0 |
| 2014 (1) | 14.52 | 118.67 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 166 | 59.62 |
